Home Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research
 

Keywords :   


Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research

2016-03-25 03:28:33| Biotech - Topix.net

According to Zacks, "Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives.

Tags: research rating hold investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Atlantic Tropical Weather Outlook
01.11Eastern North Pacific Tropical Weather Outlook
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
More »